Evidence map›Paper›PMID 17889308›Full record

ArticleAlcohol (Fayetteville, N.Y.)2007

Alveolar type II cells from ethanol-fed rats produce a fibronectin-enriched extracellular matrix that promotes monocyte activation.

Lou Ann S Brown, Jeffrey D Ritzenthaler, David M Guidot, Jesse Roman

Open access · greenAbstract read
In one paragraph

Article in Alcohol (Fayetteville, N.Y.), 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Chronic alcohol ingestion primes the lung for bleomycin-induced fibrosis in mice.Alcoholism, clinical and experimental research · 2014
    Article
  4. Chronic alcohol ingestion and predisposition to lung "cirrhosis".Alcoholism, clinical and experimental research · 2014
    Article
  5. Nicotinic acetylcholine receptors are sensors for ethanol in lung fibroblasts.Alcoholism, clinical and experimental research · 2013
    Article
  6. Review
  7. Extracellular matrix influences alveolar epithelial claudin expression and barrier function.American journal of respiratory cell and molecular biology · 2010
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Lou Ann S BrownDepartment of Pediatrics, Division of Neonatology, Emory University School of Medicine, 2015 Uppergate Drive, Atlanta, GA 30322, USA. lbrow03@emory.edu
Jeffrey D Ritzenthaler
David M Guidot
Jesse Roman
Emory University · USVeterans Health Administration · US

Funding

THE ROLE OF TGFB IN ETHANOL MEDIATED LUNG INJURYP50AA013757 · NIAAA · EMORY UNIVERSITY · PI GUIDOT, DAVID MARSHALL · 2003 to 2013
$15.7M
CHRONIC ETHANOL: MITOCHONDRIAL DYSFUNCTION AND APOPTOSISR01AA012197 · NIAAA · EMORY UNIVERSITY · PI BROWN, LOU ANN S · 2000 to 2010
$2.7M
ALCOHOLISM:ALTERED ALVEOLAR MATRIX AND ACUTE LUNG INJURYR01HL067399 · NHLBI · EMORY UNIVERSITY · PI BROWN, LOU ANN SCISM · 2000 to 2003
$908k
NHLBI NIH HHS R01 HL067399NHLBI NIH HHS R01 HL67399NIAAA NIH HHS P50 AA013757NIAAA NIH HHS P50 AA 135757NIAAA NIH HHS R01 AA012197NIAAA NIH HHS R01 AA12197
6 · The paper itself

Abstract

Acute lung injury affects close to 200,000 people in the United States annually and leads to death in 40-50% of the affected patients. Chronic ethanol abuse is thought to contribute to up to 40-50% of subjects who develop acute lung injury. We previously demonstrated in a rat model that chronic ethanol ingestion promoted acute lung injury and associated with chronic oxidant stress, activated matrix metalloproteinases, increased release of transforming growth factor-beta, and increased expression and deposition of fibronectin, a matrix glycoprotein implicated in lung injury and repair. Because fibronectin can activate monocytes to increase pro-inflammatory cytokine expression, we hypothesized that generation of fibronectin-enriched matrices during chronic ethanol ingestion might contribute to the development of acute lung injury by stimulating unopposed inflammation. To test this hypothesis, we harvested alveolar type II cells from rats fed the Lieber-DeCarli diet (6 weeks; 36% of calories from ethanol). After 96h of culture, the matrices deposited ex vivo by the type II cells derived from ethanol-fed rats showed increased amounts of fibronectin protein as demonstrated by ELISA. When monocytic U937 cells were plated atop these matrices, there was increased expression of interleukin-1beta (IL-1beta). This stimulation was inhibited by antibodies against alpha5beta1, a receptor that mediates many of the biological effects of fibronectin. We then tested whether antioxidants ameliorated these effects. Dietary supplements of the antioxidants N-acetylcysteine and procysteine normalized matrix production by type II cells. Furthermore, the newly derived matrices did not stimulate IL-1beta expression over control cells. These studies suggest that chronic ethanol exposure induces oxidant stress and activates lung tissue remodeling characterized by increased expression of fibronectin by alveolar type II cells. The newly deposited fibronectin-enriched matrices may stimulate the expression of pro-inflammatory cytokines in monocytic cells recruited to the lung after injury thereby explaining the priming effects of ethanol.

Indexed as

AcetylcysteineAlcohol DrinkingAnimalsAntioxidantsCells, CulturedCentral Nervous System DepressantsEthanolExtracellular MatrixFibronectinsHumansInterleukin-1betaMaleModels, AnimalMonocytesOxidative StressPulmonary Alveoli2-oxothiazolidine-4-carboxylic acidAcetylcysteineAntioxidantsCentral Nervous System DepressantsEthanolFibronectinsInterleukin-1betaPyrrolidonecarboxylic AcidThiazolidines

Identifiers

PMID17889308
PMCPMC2034513
OpenAlexW1987822737

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.